Annual Current Assets
$189.43 M
-$275.23 M-59.23%
December 31, 2024
Summary
- As of March 12, 2025, AMLX annual total current assets is $189.43 million, with the most recent change of -$275.23 million (-59.23%) on December 31, 2024.
- During the last 3 years, AMLX annual current assets has risen by +$84.48 million (+80.50%).
- AMLX annual current assets is now -59.23% below its all-time high of $464.67 million, reached on December 31, 2023.
Performance
AMLX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$189.43 M
-$55.83 M-22.76%
December 31, 2024
Summary
- As of March 12, 2025, AMLX quarterly total current assets is $189.43 million, with the most recent change of -$55.83 million (-22.76%) on December 31, 2024.
- Over the past year, AMLX quarterly current assets has dropped by -$275.23 million (-59.23%).
- AMLX quarterly current assets is now -59.23% below its all-time high of $464.67 million, reached on December 31, 2023.
Performance
AMLX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
AMLX Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -59.2% | -59.2% |
3 y3 years | +80.5% | -56.4% |
5 y5 years | +5816.1% | -56.4% |
AMLX Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -59.2% | +80.5% | -59.2% | +80.5% |
5 y | 5-year | -59.2% | +5816.1% | -59.2% | +1288.9% |
alltime | all time | -59.2% | +5816.1% | -59.2% | +1288.9% |
Amylyx Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $4.20 M(-92.0%) | $189.43 M(-22.8%) |
Sep 2024 | - | $245.26 M(-24.9%) |
Jun 2024 | - | $326.72 M(-20.4%) |
Mar 2024 | - | $410.53 M(-11.6%) |
Dec 2023 | $52.79 M(+466.4%) | $464.67 M(+7.0%) |
Sep 2023 | - | $434.11 M(+1.6%) |
Jun 2023 | - | $427.39 M(+9.9%) |
Mar 2023 | - | $389.05 M(+1.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $9.32 M(+1305.7%) | $382.13 M(+121.9%) |
Sep 2022 | - | $172.20 M(-20.3%) |
Jun 2022 | - | $216.14 M(-18.6%) |
Mar 2022 | - | $265.49 M(+153.0%) |
Dec 2021 | $663.00 K(+42.6%) | $104.95 M(-19.2%) |
Sep 2021 | - | $129.94 M(+852.7%) |
Dec 2020 | $465.00 K(+2483.3%) | $13.64 M |
Dec 2019 | $18.00 K | - |
FAQ
- What is Amylyx Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual current assets year-on-year change?
- What is Amylyx Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly current assets year-on-year change?
What is Amylyx Pharmaceuticals annual total current assets?
The current annual current assets of AMLX is $189.43 M
What is the all time high annual current assets for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual total current assets is $464.67 M
What is Amylyx Pharmaceuticals annual current assets year-on-year change?
Over the past year, AMLX annual total current assets has changed by -$275.23 M (-59.23%)
What is Amylyx Pharmaceuticals quarterly total current assets?
The current quarterly current assets of AMLX is $189.43 M
What is the all time high quarterly current assets for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly total current assets is $464.67 M
What is Amylyx Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, AMLX quarterly total current assets has changed by -$275.23 M (-59.23%)